However, the value of MLR was higher in CLL patients with negative clinical and laboratory prognostic factors, i.e., increased percentage of CD5+/CD19+ cells with ZAP-70 and CD38 expression. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.